These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 33995421)

  • 1. Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease.
    Lelas A; Greinix HT; Wolff D; Eissner G; Pavletic SZ; Pulanic D
    Front Immunol; 2021; 12():676756. PubMed ID: 33995421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma factor VIII and von Willebrand factor in women with type 2 diabetes: inflammatory reaction, endothelial perturbation or else?
    Soares AL; Kazmi RS; Borges MA; Rosário PW; Fernandes AP; Sousa MO; Lwaleed BA; Carvalho MG
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):600-5. PubMed ID: 21934489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological Roles of the von Willebrand Factor-Factor VIII Interaction.
    Kiouptsi K; Reinhardt C
    Subcell Biochem; 2020; 94():437-464. PubMed ID: 32189311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
    Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
    Front Immunol; 2020; 11():575492. PubMed ID: 33193367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models.
    Denis CV; Kwack K; Saffaripour S; Maganti S; André P; Schaub RG; Wagner DD
    Blood; 2001 Jan; 97(2):465-72. PubMed ID: 11154224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial Dysfunction, Atherosclerosis, and Increase of von Willebrand Factor and Factor VIII: A Randomized Controlled Trial in Swine.
    Atiq F; van de Wouw J; Sorop O; Heinonen I; de Maat MPM; Merkus D; Duncker DJ; Leebeek FWG
    Thromb Haemost; 2021 May; 121(5):676-686. PubMed ID: 33506473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.
    Kotani A; Ishikawa T; Matsumura Y; Ichinohe T; Ohno H; Hori T; Uchiyama T
    Blood; 2001 Nov; 98(10):3162-4. PubMed ID: 11698307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances and research progress in biomarkers for chronic graft versus host disease.
    Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
    Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting FVIII expression to endothelial cells regenerates a releasable pool of FVIII and restores hemostasis in a mouse model of hemophilia A.
    Shi Q; Fahs SA; Kuether EL; Cooley BC; Weiler H; Montgomery RR
    Blood; 2010 Oct; 116(16):3049-57. PubMed ID: 20606161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
    Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Hiller E
    Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
    Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of exercise, DDAVP, and epinephrine on the factor VIII:C/von Willebrand factor complex in normal dogs and von Willebrand factor deficient Doberman pinscher dogs.
    Meyers KM; Wardrop KJ; Dodds WJ; Brassard J
    Thromb Res; 1990 Jan; 57(1):97-108. PubMed ID: 2105540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor and factor VIII in renal transplant recipients under immunosuppression with cyclosporine and steroids. Sequential measurements over 4 months in 17 patients.
    Huser B; Lämmle B; Landmann J; Tran TH; Oberholzer M; Marbet GA; Thiel G; Mihatsch MJ; Duckert F
    Clin Nephrol; 1990 Nov; 34(5):214-22. PubMed ID: 2125251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions.
    Jacquemin M
    Acta Haematol; 2009; 121(2-3):102-5. PubMed ID: 19506355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.
    Lau CS; McLaren M; Belch JJ
    Br J Rheumatol; 1991 Dec; 30(6):433-6. PubMed ID: 1747698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study.
    Prenc E; Pulanic D; Pucic-Bakovic M; Ugrina I; Desnica L; Milosevic M; Pirsl F; Mitchell S; Rose J; Vrhovac R; Nemet D; Lauc G; Pavletic SZ
    Front Immunol; 2021; 12():633214. PubMed ID: 34335560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling-based identification of CD28 and PI3K as new biomarkers for chronic graft-versus-host disease.
    Lai P; Weng J; Lu Z; Guo R; Luo C; Wu S; Ling W; Geng S; Du X
    DNA Cell Biol; 2011 Dec; 30(12):1019-25. PubMed ID: 21682596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular trafficking of factor VIII to von Willebrand factor storage granules.
    Rosenberg JB; Foster PA; Kaufman RJ; Vokac EA; Moussalli M; Kroner PA; Montgomery RR
    J Clin Invest; 1998 Feb; 101(3):613-24. PubMed ID: 9449695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in chronic graft-versus-host disease.
    Rozmus J; Schultz KR
    Expert Rev Hematol; 2011 Jun; 4(3):329-42. PubMed ID: 21668397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.